General
KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
TOKYO, Mar 31, 2021 – (JCN Newswire) – KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., and Eisai
Fiscal & Financing
The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021
Canada NewsWire KELOWNA, BC , April 1, 2021 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the
Covid-19
Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
Canada NewsWire Health Canada’s Approval of FOCLIVIA ® (An Adjuvanted, Egg-Based A Strain H5N1 Pandemic Influenza Vaccine) Meets Key
Pharmaceutical
Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China
Canada NewsWire BOSTON and BEIJING, Jan. 26, 2021/CNW/ —Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for
